1,3-Dicyclohexylimidazolium chloride
CAS: 181422-72-0
Ref. 3D-FD139020
| 1g | Descatalogado | ||
| 2g | Descatalogado | ||
| 5g | Descatalogado | ||
| 10g | Descatalogado | ||
| 25g | Descatalogado |
Información del producto
Nombre:
1,3-Dicyclohexylimidazolium chloride
Descripción:
1,3-Dicyclohexylimidazolium chloride is a synthetic chemical that can be used in cancer therapy. It is the first example of an imidazolium cation that has been shown to be a potent inhibitor of glyoxalase I, an enzyme involved in the conversion of glyoxal to D-lactate. 1,3-Dicyclohexylimidazolium chloride has shown anticancer activity against prostate and breast cancer cells in vitro and in vivo. This compound also inhibits serine proteases such as plasmin and cathepsin B. Studies have shown that 1,3-dicyclohexylimidazolium chloride inhibits mitochondrial matrix enzymes such as succinate dehydrogenase and cytochrome c oxidase. The protonation state is important for determining the reactivity of this molecule with other biomolecules.
Aviso:
Nuestros productos están destinados únicamente para uso en laboratorio. Para cualquier otro uso, por favor contáctenos.
Marca:
Biosynth
Almacenamiento de larga duración:
Notas:
Propiedades químicas
Peso molecular:
268.83 g/mol
Fórmula:
C15H25ClN2
Pureza:
Min. 95%
MDL:
Punto de fusión:
Punto de ebullición:
Punto de inflamabilidad:
Densidad:
Concentración:
EINECS:
Merck:
Código HS:
